Skip to content
HowShorted

Coherus Oncology, Inc. short interest in 2026

In 2026, Coherus Oncology, Inc.'s disclosed short interest ran from 24.60% of shares outstanding on 15 Jan 2026 to 14.79% on 15 Sep 2026, a change of -9.81 percentage points. The year's high was 24.60% on 15 Jan 2026 and its low 14.79% on 15 Sep 2026, averaging 19.47% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 53.59 days on 31 Jul 2026. Full history: Coherus Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Coherus Oncology, Inc. in 2026

2026 in figures

Start of year
24.60% (15 Jan 2026)
End of year
14.79% (15 Sep 2026)
Change
-9.81 pp
High
24.60% (15 Jan 2026)
Low
14.79% (15 Sep 2026)
Average
19.47%
Highest days to cover
53.59 (31 Jul 2026)
SEC filings marked
7

Every report in 2026

Coherus Oncology, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202624.60%18.03results (8-K)
30 Jan 202624.49%5.77
13 Feb 202624.50%12.22
27 Feb 202622.88%20.59
13 Mar 202623.19%17.4910-K filed, results (8-K)
31 Mar 202623.28%20.68
15 Apr 202623.14%34.70
30 Apr 202618.03%25.51
15 May 202618.22%17.1610-Q filed, results (8-K)
29 May 202618.07%23.66
15 Jun 202616.62%33.41
30 Jun 202616.84%21.88
15 Jul 202615.49%24.36
31 Jul 202615.88%53.59
14 Aug 202615.53%19.7110-Q filed, results (8-K)
31 Aug 202615.48%16.84
15 Sep 202614.79%32.76

See also: Coherus Oncology, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.